however , ceftriaxone , a new third-generation cephalosporin , has been shown to have a long half-life ( 8 h ) and excellent in vitro efficacy against neiserria gonorrhoeae ( including penicillinase-producing strains ) and haemophilis ducreyi .
C0007561
ceftriaxone
C0018081
gonorrhoeae